大脑组织和细胞外囊中的线粒体功能障碍 脆弱的X关联震/无氧综合征
Pamela J Yao1, Apostolos Manolopoulos1, Erden Eren1
1Laboratory of Clinical Investigation, Intramural Research Program, National Institute on Aging, National Institutes of Health, Baltimore, Maryland, USA.
Annals of clinical and translational neurology
|May 8, 2024
概括
脆弱X关联/缺氧综合征 (FXTAS) 患者大脑小脑中的线粒体功能障碍也可检测到FMR1前变异载体的血神经元衍生细胞外囊 (NDEVs).
科学领域:
- 神经科学是一个神经科学.
- 线粒体生物学 线粒体生物学
- 遗传学 是一个遗传学.
背景情况:
- 线粒体损伤与脆弱X相关的震/缺氧综合征 (FXTAS) 病变发生有关.
- 以前的研究分析了外围组织和细胞,但FXTAS中的脑组织分析是有限的.
- 脆弱的X信使核糖蛋白1 (FMR1) 基因前变异携带者可以发展FXTAS.
研究的目的:
- 为了调查FXTAS患者死后脑组织中的线粒体异常.
- 评估这些异常是否存在于早期无症状阶段的活体FMR1前变异载体的神经元衍生细胞外囊 (NDEVs) 中.
主要方法:
- 在 FXTAS 患者和对照者的死后小脑和额叶皮层样本中,比较了线粒体复合体 IV 和 V 的数量和活性.
- 通过使用L1CAM免疫亲和捕获,从FMR1前变异载体和对照体中分离的血NDEV中分析了相同的线粒体测量.
主要成果:
- 在FXTAS患者中,小脑的复杂IV和V数量和活动减少,但前额叶皮层没有.
- 携带FMR1前变异的携带者在血NDEV中IV和V复合物的活性较低.
- 与对照组相比,FMR1前变异载体在血NDEV中表现出更高的复杂V量.
结论:
- 线粒体电子运输链复合体IV和V异常在FXTAS小脑中反映在FMR1前变异载体的血NDEV中.
- 血NDEVs可能为FXTAS中的线粒体病理提供见解.
- 血NDEV可以作为预测症状FXTAS和监测携带者疾病进展的潜在生物标志物.
相关概念视频
ATP Synthase: Mechanism
14.5K
In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased...
14.5K
Amyloid Fibrils
9.5K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.5K


